Santaris Pharma Investors

31 investors on Angel Roster list Santaris Pharma in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the Netherlands, the United States and the United Kingdom.

Investors are matched on the company name in their portfolio, so companies that share the name Santaris Pharma can appear together.

Investors listed
31
With verified email
26%
Most common stage
Seed
Top location
Netherlands

Updated October 13, 2026 · How we compile this data

Top 31 Santaris Pharma investors

The most complete profiles first. Showing 31 of 31.

  • Annie MitsakVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more

    Verified email available

  • Antoine BoulangerVerified

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Verified email available

  • Anastasia KarpovaVerified

    Venture Capital · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Verified email available

  • AnneVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more

    Verified email available

  • Boyd RuttenVerified

    Venture Capital, Private Equity Firm · Netherlands

    Health CareWearablesHospitalsWellness

    Portfolio: Santaris Pharma, Noema Pharma, AM Pharma, Sapiens Steering Brain Stimulation and 51 more

    Verified email available

  • Henry ZubaidaVerified

    Venture Capital, Private Equity Firm · United Kingdom

    Health CareWearablesHospitalsWellness

    Portfolio: Santaris Pharma, Noema Pharma, AM Pharma, Sapiens Steering Brain Stimulation and 51 more

    Verified email available

  • John MontanaVerified

    Venture Capital, Private Equity Firm, Investment Partner · United Kingdom

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Verified email available

  • Paulina HillVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more

    Verified email available

  • Francesco Draetta

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more

    Contact details available

  • Geert

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Holger Reithinger

    Venture Capital, Investor · Germany

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 64 more

    Contact details available

  • Juliette Audet

    Venture Capital, Investor · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Katie Kerfoot

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more

    Contact details available

  • Martien van Osch

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 64 more

    Contact details available

  • Michelle Doig

    Venture Capital, Investor · Canada

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more

    Contact details available

  • Rogier Rooswinkel

    Venture Capital, Investor · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Wouter Joustra

    Venture Capital, Investor · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Asiya Giniatullina

    Venture Capital · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Bonnie van Wilgenburg

    Venture Capital · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Carlo Incerti

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Dan Secor

    Venture Capital, Private Equity Firm · United States

    Health CareWearablesHospitalsWellness

    Portfolio: Santaris Pharma, Noema Pharma, AM Pharma, Sapiens Steering Brain Stimulation and 51 more

    Contact details available

  • Edward Hanlon

    Venture Capital, Private Equity Firm · United States

    Health CareWearablesHospitalsWellness

    Portfolio: Santaris Pharma, Noema Pharma, AM Pharma, Sapiens Steering Brain Stimulation and 51 more

    Contact details available

  • Edwin de Graaf

    Venture Capital, Private Equity Firm · Netherlands

    Health CareWearablesHospitalsWellness

    Portfolio: Santaris Pharma, Noema Pharma, AM Pharma, Sapiens Steering Brain Stimulation and 51 more

    Contact details available

  • Jasper van Gorp

    Venture Capital, Private Equity Firm · Netherlands

    Health CareWearablesHospitalsWellness

    Portfolio: Santaris Pharma, Noema Pharma, AM Pharma, Sapiens Steering Brain Stimulation and 51 more

    Contact details available

  • Joep Heldens

    Venture Capital, Private Equity Firm · Netherlands

    Health CareWearablesHospitalsWellness

    Portfolio: Santaris Pharma, Noema Pharma, AM Pharma, Sapiens Steering Brain Stimulation and 51 more

    Contact details available

  • Redmar Koene

    Venture Capital, Private Equity Firm · Netherlands

    Health CareWearablesHospitalsWellness

    Portfolio: Santaris Pharma, Noema Pharma, AM Pharma, Sapiens Steering Brain Stimulation and 51 more

    Contact details available

  • Sander van Deventer

    Venture Capital · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Sanne de Jongh

    Venture Capital, Private Equity Firm · Netherlands

    Health CareWearablesHospitalsWellness

    Portfolio: Santaris Pharma, Noema Pharma, AM Pharma, Sapiens Steering Brain Stimulation and 51 more

    Contact details available

  • Stefan Luzi, PhD

    Venture Capital, Private Equity Firm · Netherlands

    Health CareWearablesHospitalsWellness

    Portfolio: Santaris Pharma, Noema Pharma, AM Pharma, Sapiens Steering Brain Stimulation and 51 more

    Contact details available

  • Tom Klein Robbenhaar

    Venture Capital, Private Equity Firm · Netherlands

    Health CareWearablesHospitalsWellness

    Portfolio: Santaris Pharma, Noema Pharma, AM Pharma, Sapiens Steering Brain Stimulation and 51 more

    Contact details available

  • Vincent van Houten

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

Frequently asked questions

How many Santaris Pharma investors are on Angel Roster?

Angel Roster lists 31 Santaris Pharma investors. 8 of them (26%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (31), Private Equity Firms (17) and Investment Partner Investors (6). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Santaris Pharma investors invest in?

Among those that list a stage, the most common are Seed (11).

Where are Santaris Pharma investors based?

Most are based in the Netherlands (20), the United States (7) and the United Kingdom (2).

Which companies have Santaris Pharma investors backed?

The most-backed portfolio companies among them are Amphista Therapeutics (25), AM Pharma (25), Pieris AG (25), Roche Glycart (25) and SANIFIT (25).

How do I contact Santaris Pharma investors?

Create a free Angel Roster account to search and filter all 31, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.